Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic.

Authors: Nadar, Venkadesh Sarkarai; Chen, Jian; Dheeman, Dharmendra S; Galván, Adriana Emilce; Yoshinaga-Sakurai, Kunie; Kandavelu, Palani; Sankaran, Banumathi; Kuramata, Masato; Ishikawa, Satoru; Rosen, Barry P; Yoshinaga, Masafumi

Published In Commun Biol, (2019)

Abstract: The emergence and spread of antimicrobial resistance highlights the urgent need for new antibiotics. Organoarsenicals have been used as antimicrobials since Paul Ehrlich's salvarsan. Recently a soil bacterium was shown to produce the organoarsenical arsinothricin. We demonstrate that arsinothricin, a non-proteinogenic analog of glutamate that inhibits glutamine synthetase, is an effective broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria, suggesting that bacteria have evolved the ability to utilize the pervasive environmental toxic metalloid arsenic to produce a potent antimicrobial. With every new antibiotic, resistance inevitably arises. The arsN1 gene, widely distributed in bacterial arsenic resistance (ars) operons, selectively confers resistance to arsinothricin by acetylation of the α-amino group. Crystal structures of ArsN1 N-acetyltransferase, with or without arsinothricin, shed light on the mechanism of its substrate selectivity. These findings have the potential for development of a new class of organoarsenical antimicrobials and ArsN1 inhibitors.

PubMed ID: 30993215 Exiting the NIEHS site

MeSH Terms: Acetylation; Anti-Bacterial Agents/chemistry*; Anti-Bacterial Agents/isolation & purification; Anti-Bacterial Agents/pharmacology*; Arsenicals/chemistry*; Arsenicals/isolation & purification; Arsenicals/pharmacology*; Burkholderia gladioli/drug effects; Burkholderia gladioli/metabolism*; Cell Survival/drug effects; Drug Resistance, Multiple, Bacterial/drug effects; Escherichia coli/drug effects; Escherichia coli/metabolism; Genes, Bacterial/genetics; Glutamate-Ammonia Ligase/analysis; Glutamic Acid/analogs & derivatives*; Humans; Microbial Sensitivity Tests; Mycobacterium bovis/drug effects; Operon; THP-1 Cells

to Top